Brett A. Grimaud - 20 Nov 2025 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, GEN COUNSEL AND SECRETARY
Signature
/s/ Corinna Liebowitz, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
20 Nov 2025
Transactions value $
-$340,530
Form type
4
Filing time
24 Nov 2025, 18:13:03
Previous filing
22 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY C/O THERAVANCE BIOPHARMA US, LLC, 901 GATEWAY BLVD, SOUTH SAN FRANCISCO /s/ Corinna Liebowitz, Attorney-in-Fact 24 Nov 2025 0001966698

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability -$341K -19K -5.08% $17.90 355K 20 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.